Chemical Name: 1,2-Benzisoxazole-3-methanesulfonamide
Biological ActivityAntiepileptic that possesses a broad spectrum anticonvulsant and mechanistic profile. Blocks voltage-sensitive Na+ and T-type Ca2+ channels, stimulates BKCa channels, modulates GABA, glutamate and monoamine neurotransmission, inhibits lipid peroxidation and scavenges hydroxyl and nitric oxide free radicals. Displays neuroprotective and antiParkinsonian activity.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Zonisamide: a new antiepileptic drug.
Sobieszek et al.
Novel DA releasing response of an anti-convulsant agent with possible anti-Parkinson's activity.
Gluck et al.
J.Neural Transm., 2004;111:713
Activation by Zonisamide, a newer antiepileptic drug, of large-conductance calcium-activated potassium channel in differentiated hippocampal neuron-derived H19-7 cells.
Huang et al.
In vivo evaluation of hippocampal anti-oxidant ability of zonis. in rats.
Tokumaru et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Zonisamide
Average Rating: 5 (Based on 1 Review)
Have you used Zonisamide?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Zonisamide was used on Cav3.1 and Cav3.2 channel to understand their blocking capacities at increasing concentrations.We aimed to decrease calcium conductance through the channels as increase leads to increased depolarization and excitability.